U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar for the week of 12/01/2024 - 12/07/2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar for the week of 12/01/2024 - 12/07/2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 12/05/2024
Location: Washington, DC
Subject: FDA Alumni Association Winter Celebration
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and other invited guests

Event Date: 12/06/2024
Location: Virtual
Subject: Heart and Cardiovascular Grand Rounds - A View of Cardiovascular Disease from the FDA Commissioner
FDA Participant/Group: N/A
Non FDA Participant/Group: Several faculty and students from Augusta University and other registered guests

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 12/03/2024
Location: Virtual
Subject: Food Safety and Budget Issues of Mutual Interest
FDA Participant/Group: ERIK METTLER; MICHAEL ROGERS; 
Non FDA Participant/Group: Becky Garrison, Joe Reardon, Ted McKinney (National Association of State Departments of Agriculture);

Event Date: 12/04/2024
Location: Virtual
Subject: FDA Human Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Several staff and members of the Consumer Brands Association's Regulatory Affairs Council

Event Date: 12/06/2024
Location: Virtual
Subject: Nutrition and Public Health Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Nutrition Consumer and Public Health Alliance

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 12/04/2024
Location: Virtual
Subject: FDA Public Patient Listening Meeting 2: Patient and Care Partner Perspectives on Early Enrollment Into Gene Therapy Clinical Trials for Rare Diseases 
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 12/04/2024
Location: Baltimore, MD
Subject: TEDCO's Entrepreneur Expo 2024; Fireside Chat - Advancing Regenerative Medicine: FDA's Role in Accelerating Approvals for Innovative Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 12/05/2024
Location: Washington, DC
Subject: 1Day Sooner Conference; Panel 2 - Regulatory Science: How Regulatory Capacity and Advance Guidance Can Accelerate Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 12/04/2024
Location: Virtual 
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: TRISTAN COLONIUS; WILLIAM FLYNN; 
Non FDA Participant/Group: Representatives of Elanco

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

Back to Top